Proinflammatory cytokines - PubMed (original) (raw)
Review
Proinflammatory cytokines
C A Dinarello. Chest. 2000 Aug.
Abstract
Study objectives: To review the concept of proinflammatory cytokines.
Design: Review of published literature.
Setting: Academic (university hospital).
Results: Cytokines are regulators of host responses to infection, immune responses, inflammation, and trauma. Some cytokines act to make disease worse (proinflammatory), whereas others serve to reduce inflammation and promote healing (anti-inflammatory). Attention also has focused on blocking cytokines, which are harmful to the host, particularly during overwhelming infection. Interleukin (IL)-1 and tumor necrosis factor (TNF) are proinflammatory cytokines, and when they are administered to humans, they produce fever, inflammation, tissue destruction, and, in some cases, shock and death. Reducing the biological activities of IL-1 and TNF is accomplished by several different, but highly specific, strategies, which involve neutralizing antibodies, soluble receptors, receptor antagonist, and inhibitors of proteases that convert inactive precursors to active, mature molecules. Blocking IL-1 or TNF has been highly successful in patients with rheumatoid arthritis, inflammatory bowel disease, or graft-vs-host disease but distinctly has not been successful in humans with sepsis. Agents such as TNF-neutralizing antibodies, soluble TNF receptors, and IL-1 receptor antagonist have been infused into > 10,000 patients in double-blind, placebo-controlled trials. Although there has been a highly consistent small increase (2 to 3%) in 28-day survival rates with anticytokine therapy, the effect has not been statistically significant.
Conclusions: Anticytokine therapy should be able to "rescue" the patient whose condition continues to deteriorate in the face of considerable support efforts. Unfortunately, it remains difficult to identify those patients who would benefit from anticytokine therapy for septic shock.
Similar articles
- Anti-cytokine therapies in response to systemic infection.
Dinarello CA. Dinarello CA. J Investig Dermatol Symp Proc. 2001 Dec;6(3):244-50. doi: 10.1046/j.0022-202x.2001.00046.x. J Investig Dermatol Symp Proc. 2001. PMID: 11924836 Review. - Cytokines and soluble cytokine receptors in pleural effusions from septic and nonseptic patients.
Marie C, Losser MR, Fitting C, Kermarrec N, Payen D, Cavaillon JM. Marie C, et al. Am J Respir Crit Care Med. 1997 Nov;156(5):1515-22. doi: 10.1164/ajrccm.156.5.9702108. Am J Respir Crit Care Med. 1997. PMID: 9372669 - Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE, Tetlow LC. Woolley DE, et al. Arthritis Res. 2000;2(1):65-74. doi: 10.1186/ar70. Arthritis Res. 2000. PMID: 11219391 Free PMC article. - The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome.
Dinarello CA. Dinarello CA. J Infect Dis. 1991 Jun;163(6):1177-84. doi: 10.1093/infdis/163.6.1177. J Infect Dis. 1991. PMID: 2037782 Review. - Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus.
Tillie-Leblond I, Pugin J, Marquette CH, Lamblin C, Saulnier F, Brichet A, Wallaert B, Tonnel AB, Gosset P. Tillie-Leblond I, et al. Am J Respir Crit Care Med. 1999 Feb;159(2):487-94. doi: 10.1164/ajrccm.159.2.9805115. Am J Respir Crit Care Med. 1999. PMID: 9927362
Cited by
- Ficolin-2 amplifies inflammation in macrophage-smooth muscle cell cross-talk and increases monocyte transmigration by mechanisms involving IL-1β and IL-6.
Macarie RD, Tucureanu MM, Ciortan L, Gan AM, Butoi E, Mânduțeanu I. Macarie RD, et al. Sci Rep. 2023 Nov 8;13(1):19431. doi: 10.1038/s41598-023-46770-0. Sci Rep. 2023. PMID: 37940674 Free PMC article. - Feeding-induced resistance to acute lethal sepsis is dependent on hepatic BMAL1 and FXR signalling.
Geiger SS, Traba J, Richoz N, Farley TK, Brooks SR, Petermann F, Wang L, Gonzalez FJ, Sack MN, Siegel RM. Geiger SS, et al. Nat Commun. 2021 May 12;12(1):2745. doi: 10.1038/s41467-021-22961-z. Nat Commun. 2021. PMID: 33980856 Free PMC article. - Interleukin-6 is linked to longitudinal rates of cortical thinning in aging.
McCarrey AC, Pacheco J, Carlson OD, Egan JM, Thambisetty M, An Y, Ferrucci L, Resnick SM. McCarrey AC, et al. Transl Neurosci. 2014 Mar;5(1):1-7. doi: 10.2478/s13380-014-0203-0. Transl Neurosci. 2014. PMID: 27066268 Free PMC article. - Humoral sleep regulation; interleukin-1 and tumor necrosis factor.
Jewett KA, Krueger JM. Jewett KA, et al. Vitam Horm. 2012;89:241-57. doi: 10.1016/B978-0-12-394623-2.00013-5. Vitam Horm. 2012. PMID: 22640617 Free PMC article. Review. - Novel anti-inflammatory activity of epoxyazadiradione against macrophage migration inhibitory factor: inhibition of tautomerase and proinflammatory activities of macrophage migration inhibitory factor.
Alam A, Haldar S, Thulasiram HV, Kumar R, Goyal M, Iqbal MS, Pal C, Dey S, Bindu S, Sarkar S, Pal U, Maiti NC, Bandyopadhyay U. Alam A, et al. J Biol Chem. 2012 Jul 13;287(29):24844-61. doi: 10.1074/jbc.M112.341321. Epub 2012 May 29. J Biol Chem. 2012. PMID: 22645149 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources